The world’s first ‘RSV vaccine’ has been successfully immunized. ‘From mother to child’ Pfizer to file registration this year
Dr. Anan Chongkaewwatana Director of Animal Health and Management Innovation Research Group National Center for Genetic Engineering and Biotechnology (Biotech) posted a Facebook page. Anan Jongkaewwattana About the Pfizer Vaccine Camp can research and produce vaccines RSV which will build immunity from mother and child has been the first success in the world Message as follows
good news vaccineRSV Pfizer’s through phase 3 has been very effective, able to prevent severe RSV symptoms in children from postpartum to 3 months of age with 81.8% of protection efficiency and Phum will continue to live until 6-month-old babies at 69.4%.
Prepare to apply for registration this year.
The vaccine is bivalent, designed for 2 RSV strains and administered to mothers during pregnancy. To pass from mother to child, Pfizer plans to apply for a license to use the vaccine this year. If the FDA gives a green light, it will be considered an RSV vaccine. The first to use the landscape from mother to child.
Read more